GO:0010138 pyrimidine ribonucleotide salvage: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010138 pyrimidine ribonucleotide salvage is the biological process that converts pyrimidine bases or pyrimidine ribonucleosides derived from nucleotide breakdown back into pyrimidine ribonucleotides.
• The salvage route is essential when de novo pyrimidine biosynthesis is absent or insufficient, and it supports DNA replication, RNA synthesis and mitochondrial transcription.
• Key enzymes include uridine phosphorylase, uridine kinase, cytidine deaminase, uracil phosphoribosyltransferase and NUDT22, which together recycle uracil, uridine and cytidine.
• Cancer cells frequently depend on pyrimidine salvage, and blocking both de novo and salvage synthesis is a validated vulnerability in retinoblastoma and other tumors.
• NUDT22 promotes cancer growth through pyrimidine salvage, and NME6 links ribonucleotide salvage to mitochondrial transcription, showing the pathway is not housekeeping-only.
• CRISPR knockout, point-mutation, knock-in and overexpression models are the main tools for dissecting pyrimidine ribonucleotide salvage gene function in disease and metabolism.
Description
Pyrimidine ribonucleotide salvage (GO:0010138) is the biological process by which pyrimidine bases or pyrimidine ribonucleosides generated during nucleotide breakdown are converted back into pyrimidine ribonucleotides. Unlike de novo pyrimidine biosynthesis, which builds the pyrimidine ring from simple precursors, salvage recycles preformed uracil, uridine and cytidine, conserving energy and nitrogen. This pathway is especially important in cells or tissues where de novo pyrimidine nucleotide biosynthesis is absent or limited, and it directly supplies substrates for DNA replication and RNA transcription. Researchers study GO:0010138 because it sits at the intersection of nucleotide metabolism, mitochondrial function, cancer cell proliferation and therapy resistance. In cancer, pyrimidine salvage can compensate when de novo synthesis is pharmacologically blocked, making it a target for combination strategies. In mitochondria, ribonucleotide salvage sustains transcription, linking nucleotide recycling to organelle gene expression. The pathway is also relevant to microbial physiology, where control of a pyrimidine ribonucleotide salvage pathway has been characterized in Pseudomonas oleovorans. Because salvage enzymes are often dispensable in normal cells but essential in tumors or stressed cells, they are attractive candidates for CRISPR-based functional genomics.
pyrimidine ribonucleotide salvage At A Glance
| GO ID | GO:0010138 |
|---|---|
| GO term | pyrimidine ribonucleotide salvage |
| Ontology | biological_process |
| Synonym | none |
| Major function | Recycles pyrimidine bases and pyrimidine ribonucleosides from nucleotide breakdown back into pyrimidine ribonucleotides |
| Pathway context | Important where there is no de novo pyrimidine nucleotide biosynthesis |
| Key substrates | Uracil, uridine, cytidine and related pyrimidine ribonucleosides |
| Key products | UMP, CMP and downstream pyrimidine ribonucleotides |
| Representative enzymes | Uridine phosphorylase, uridine kinase, cytidine deaminase, uracil phosphoribosyltransferase, NUDT22 |
| Disease relevance | Cancer growth, retinoblastoma vulnerability, immunotherapy resistance and mitochondrial dysfunction |
What Is GO:0010138?
In my own words, GO:0010138 pyrimidine ribonucleotide salvage describes the set of biochemical reactions that take pyrimidine bases (such as uracil) or pyrimidine ribonucleosides (such as uridine and cytidine) released by nucleotide breakdown and rebuild them into pyrimidine ribonucleotides (such as UMP, CMP and their phosphorylated derivatives). The QuickGO definition emphasizes that this salvage pathway is important where there is no de novo pyrimidine nucleotide biosynthesis. It is a biological process, not a single enzyme or complex, and it includes transport, phosphorolysis, deamination, phosphoribosylation and phosphorylation steps that together restore the pyrimidine ribonucleotide pool.
Why Is pyrimidine ribonucleotide salvage Important in Cell Biology?
GO:0010138 matters because pyrimidine ribonucleotide salvage is a central supply route for the nucleotides needed for DNA replication and RNA synthesis, particularly when de novo pyrimidine biosynthesis is absent or blocked. In cancer, salvage can rescue tumor cells from de novo synthesis inhibitors, and combined blockade of both routes has shown efficacy in retinoblastoma models. Nucleotide metabolism in cancer cells also fuels UDP-driven macrophage cross-talk that promotes immunosuppression and immunotherapy resistance, connecting salvage to the tumor microenvironment. In mitochondria, NME6-dependent ribonucleotide salvage sustains mitochondrial transcription, so the pathway influences organelle gene expression and cellular energetics. NUDT22 promotes cancer growth through pyrimidine salvage, providing a direct link between a salvage enzyme and tumor proliferation. Together, these findings make GO:0010138 a high-value process for metabolic, oncological and mitochondrial research.
• Supplies pyrimidine ribonucleotides for DNA replication and RNA transcription when de novo synthesis is absent.
• Enables cancer cells to survive pharmacological blockade of de novo pyrimidine synthesis.
• Contributes to UDP-driven macrophage cross-talk and immunotherapy resistance in tumors.
• Sustains mitochondrial transcription through NME6-linked ribonucleotide salvage.
• Promotes cancer growth via NUDT22-dependent pyrimidine salvage.
• Is a validated vulnerability in retinoblastoma when combined with de novo synthesis blockage.
• Links nucleotide metabolism to DNA repair and therapy resistance in glioblastoma.
• Provides metabolic flexibility in microorganisms such as Pseudomonas oleovorans.
• Offers CRISPR-tractable enzyme targets for metabolic and oncological studies.
• Connects pyrimidine recycling to oxidative damage and mitochondrial dysfunction in aging tissues.
What Happens During pyrimidine ribonucleotide salvage?
Release of pyrimidine bases and ribonucleosides from nucleotide breakdown
In simple terms: First, old nucleotides are broken down and their pyrimidine parts are released for recycling.
Pyrimidine ribonucleotide salvage begins with the degradation of existing nucleotides, which releases pyrimidine bases such as uracil and pyrimidine ribonucleosides such as uridine and cytidine. These breakdown products are the substrates that the salvage pathway recycles, and their availability determines flux through GO:0010138. In cells with no de novo pyrimidine nucleotide biosynthesis, this release step is the main source of salvageable pyrimidine precursors.
Phosphorolysis and deamination of pyrimidine ribonucleosides
In simple terms: Enzymes then convert uridine and cytidine into uracil and other reusable forms.
Uridine phosphorylase cleaves uridine into uracil and ribose-1-phosphate, while cytidine deaminase converts cytidine to uridine, feeding the salvage pool. These reactions allow the pathway to interconvert pyrimidine ribonucleosides and bases so that they can be reutilized. In Pseudomonas oleovorans, control of a pyrimidine ribonucleotide salvage pathway has been experimentally characterized, showing that these enzymatic steps are regulated in response to metabolic demand.
Phosphoribosylation and phosphorylation to rebuild pyrimidine ribonucleotides
In simple terms: The salvaged bases are reattached to ribose phosphate and phosphorylated to remake UMP and CMP.
Uracil phosphoribosyltransferase converts uracil and phosphoribosyl pyrophosphate into UMP, and uridine kinase phosphorylates uridine to UMP, restoring the pyrimidine ribonucleotide pool. These reactions are the core of GO:0010138 because they directly regenerate pyrimidine ribonucleotides from breakdown products. The resulting UMP and CMP can be further phosphorylated to UDP, UTP, CDP and CTP for nucleic acid synthesis.
Salvage-dependent support of DNA replication and RNA synthesis
In simple terms: The rebuilt nucleotides are used to copy DNA and make RNA.
Once pyrimidine ribonucleotides are regenerated, they are incorporated into DNA and RNA, linking GO:0010138 to replication and transcription. Nucleotide metabolism and DNA replication are tightly coordinated, so salvage flux must match cell cycle demand. In cancer cells, this salvage-dependent supply can sustain proliferation even when de novo synthesis is inhibited.
Mitochondrial ribonucleotide salvage and transcription
In simple terms: Inside mitochondria, salvage also provides nucleotides needed to transcribe mitochondrial DNA.
NME6-dependent ribonucleotide salvage sustains mitochondrial transcription, showing that GO:0010138 operates in mitochondrial nucleotide pools as well as the cytosol. This mitochondrial arm connects pyrimidine salvage to organelle gene expression and cellular energy metabolism. Defects in this process may contribute to mitochondrial dysfunction observed in aging tissues.
NUDT22 and cancer-associated pyrimidine salvage
In simple terms: Some tumors use specific salvage enzymes such as NUDT22 to grow.
NUDT22 promotes cancer growth through pyrimidine salvage, providing a direct example of how GO:0010138 can be co-opted in malignancy. Targeting NUDT22 or related salvage enzymes may therefore reduce tumor proliferation. Combined de novo and salvage pyrimidine ribonucleotide synthesis blockade is a validated strategy in retinoblastoma, confirming that salvage is a therapeutic vulnerability.
Key Genes Involved in GO:0010138 pyrimidine ribonucleotide salvage
The following genes and proteins are experimentally implicated in pyrimidine ribonucleotide salvage (GO:0010138) or in its regulation and disease relevance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UPP1 | Uridine phosphorylase that cleaves uridine to uracil and ribose-1-phosphate | Controls salvage flux and is studied in cancer metabolism |
| UPP2 | Uridine phosphorylase isoform involved in pyrimidine base release | Tissue-specific salvage regulation |
| UCK1 | Uridine kinase that phosphorylates uridine to UMP | Rate-limiting step in pyrimidine ribonucleotide salvage |
| UCK2 | Uridine kinase isoform supporting salvage in specific tissues | Mitochondrial and cytosolic salvage studies |
| CMPK1 | Phosphorylates CMP and UMP to diphosphates | Downstream pyrimidine ribonucleotide pool maintenance |
| CMPK2 | Mitochondrial cytidine monophosphate kinase | Mitochondrial nucleotide salvage |
| CDA | Cytidine deaminase converting cytidine to uridine | Salvage substrate interconversion |
| UPRT | Uracil phosphoribosyltransferase converting uracil to UMP | Core salvage enzyme in microbes and cancer |
| NUDT22 | Pyrimidine salvage enzyme promoting cancer growth | Direct oncogenic role in pyrimidine salvage |
| NME6 | Ribonucleotide salvage factor sustaining mitochondrial transcription | Links salvage to mitochondrial gene expression |
| NT5C | Cytosolic 5-prime nucleotidase releasing pyrimidine ribonucleosides | Generates salvage substrates from nucleotides |
| NT5M | Mitochondrial 5-prime nucleotidase | Mitochondrial pyrimidine ribonucleoside release |
| SLC29A1 | Equilibrative nucleoside transporter | Uptake of pyrimidine ribonucleosides for salvage |
| SLC29A2 | Nucleoside transporter supporting salvage substrate import | Transport-dependent salvage studies |
| SLC28A1 | Concentrative nucleoside transporter | Pyrimidine ribonucleoside uptake |
| RRM1 | Ribonucleotide reductase subunit for deoxyribonucleotide synthesis | Connects salvage to DNA replication |
| RRM2 | Ribonucleotide reductase subunit | Balances salvage and de novo pathways |
How Is pyrimidine ribonucleotide salvage Regulated?
Pyrimidine ribonucleotide salvage is regulated by substrate availability, enzyme expression and cellular demand for nucleotides. In Pseudomonas oleovorans, control of a pyrimidine ribonucleotide salvage pathway has been experimentally demonstrated, indicating that the pathway responds to metabolic signals. Nucleotide metabolism and DNA replication are coordinated so that salvage flux matches cell cycle requirements. In cancer cells, salvage can be upregulated to compensate for de novo synthesis inhibition, and combined blockade of both routes is required for efficacy in retinoblastoma. NUDT22-dependent pyrimidine salvage promotes cancer growth, suggesting that oncogenic signals can drive salvage enzyme activity. NME6-dependent ribonucleotide salvage sustains mitochondrial transcription, linking salvage regulation to mitochondrial function. Oxidative damage and mitochondrial dysfunction during ovarian aging are associated with altered nucleotide metabolism, which may indirectly affect salvage capacity.
pyrimidine ribonucleotide salvage and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NUDT22 | Cancer growth through pyrimidine salvage | CRISPR knockout in cancer cell lines |
| NME6 | Mitochondrial transcription and dysfunction | Knockout and rescue in mitochondrial reporter cells |
| UCK1 | Pyrimidine ribonucleotide supply in tumors | Point-mutation and overexpression models |
| UPP1 | Salvage flux in cancer metabolism | Knockout with metabolic flux analysis |
| CDA | Cytidine deamination and salvage substrate balance | Knock-in of patient variants |
Cancer and therapy resistance
Pyrimidine ribonucleotide salvage supports cancer cell proliferation and therapy resistance. Retinoblastoma cells are vulnerable to combined de novo and salvage pyrimidine ribonucleotide synthesis pharmacologic blockage, showing that salvage is a targetable dependency. Nucleotide metabolism in cancer cells fuels UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance. NUDT22 promotes cancer growth through pyrimidine salvage, providing a direct oncogenic mechanism. Purine metabolism regulates DNA repair and therapy resistance in glioblastoma, illustrating how nucleotide pathways broadly influence treatment response.
Mitochondrial dysfunction and aging
NME6-dependent ribonucleotide salvage sustains mitochondrial transcription, so defects in salvage can impair mitochondrial gene expression. Human ovarian aging is characterized by oxidative damage and mitochondrial dysfunction, and altered nucleotide metabolism may contribute to this phenotype. Because mitochondria rely on salvage for nucleotide supply, GO:0010138 is relevant to aging and mitochondrial disease research.
Microbial physiology and infection
Control of a pyrimidine ribonucleotide salvage pathway has been characterized in Pseudomonas oleovorans, showing that salvage is important for bacterial nucleotide homeostasis. Nucleotide metabolism and DNA replication are linked in microbial systems, making salvage enzymes potential antibacterial targets. Understanding microbial salvage can also inform host-pathogen metabolic interactions.
From pyrimidine ribonucleotide salvage-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a salvage enzyme required for cancer cell proliferation? | CRISPR knockout in cancer cell lines |
| Does a specific point mutation alter salvage enzyme activity? | CRISPR point-mutation knock-in |
| Can a tagged salvage enzyme be tracked in live cells? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression of a salvage gene increase nucleotide pools? | CRISPR overexpression model |
| Does mitochondrial salvage support transcription? | Knockout of NME6 with mitochondrial transcription readout |
| Does combined de novo and salvage blockade reduce tumor growth? | Pharmacologic blockade in retinoblastoma models |
How to Study the pyrimidine ribonucleotide salvage Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Metabolic flux analysis | Conversion of pyrimidine precursors to ribonucleotides | Quantifying salvage activity |
| RNA sequencing | Expression of salvage genes | Pathway rewiring in cancer |
| Proteomics | Protein abundance of salvage enzymes | Functional validation of CRISPR models |
| Enzyme activity assay | Catalytic activity of UPP1, UCK1, CDA, NUDT22 | Mechanistic studies |
| Mitochondrial transcription assay | Mitochondrial RNA synthesis | NME6-dependent salvage studies |
| Fluorescence imaging | Subcellular localization of tagged enzymes | Live-cell tracking |
| CRISPR knockout screening | Gene essentiality in salvage-dependent cells | Target discovery |
| Pharmacologic blockade | Combined de novo and salvage inhibition | Therapeutic vulnerability testing |
Metabolic flux analysis
Metabolic flux analysis using labeled pyrimidine precursors measures how much uracil, uridine or cytidine is converted into pyrimidine ribonucleotides through GO:0010138. This approach can quantify salvage activity in cancer cells and microbial systems. It is typically combined with CRISPR knockout of salvage enzymes to establish causality.
RNA sequencing and transcriptomics
RNA sequencing measures expression of salvage genes such as UPP1, UCK1, CDA and NUDT22 under different conditions. Transcriptomic profiling can reveal compensatory upregulation of salvage when de novo synthesis is inhibited. It is widely used to identify pathway rewiring in cancer and mitochondrial models.
Proteomics and enzyme activity assays
Proteomics and targeted enzyme activity assays measure protein levels and catalytic activity of salvage enzymes. These methods confirm whether changes in gene expression translate into functional salvage capacity. They are often paired with CRISPR knock-in of tagged enzymes for validation.
Mitochondrial transcription and imaging
Mitochondrial transcription assays and imaging measure whether ribonucleotide salvage supports organelle gene expression. Fluorescent tagging of salvage enzymes allows localization studies in live cells. These methods connect GO:0010138 to mitochondrial function and aging phenotypes.
How CRISPR Can Be Used to Study GO:0010138 pyrimidine ribonucleotide salvage
Knockout
CRISPR knockout of salvage genes such as NUDT22, UPP1 or UCK1 can test whether they are required for cancer cell proliferation or mitochondrial transcription. Knockout models are used to measure changes in pyrimidine ribonucleotide pools and sensitivity to de novo synthesis inhibitors. They are also valuable in microbial systems to study pathway control.
Point Mutation
CRISPR point-mutation knock-in can introduce catalytic-dead or patient-derived mutations in salvage enzymes to dissect their mechanism. These models help distinguish enzyme activity from scaffolding functions. They are particularly useful for NUDT22 and UCK1 structure-function studies.
Knock-in
CRISPR knock-in of tags or reporters allows tracking of salvage enzymes in live cells and tissues. Tagged knock-in models can reveal subcellular localization, including mitochondrial pools. They also enable affinity purification for interaction studies.
Overexpression
CRISPR overexpression of salvage genes can test whether increased salvage flux promotes growth or therapy resistance. Overexpression models are useful for studying NUDT22-driven cancer growth and NME6-dependent mitochondrial transcription. They can also reveal feedback regulation of the pathway.
How EDITGENE Supports pyrimidine ribonucleotide salvage Research
Researchers studying pyrimidine ribonucleotide salvage-related genes often need to determine whether a candidate gene is causally involved in nucleotide recycling, cancer growth or mitochondrial function, and CRISPR-based models provide the most direct way to test this.
Contact EDITGENE today to design your custom CRISPR model for pyrimidine ribonucleotide salvage research.
Frequently Asked Questions About pyrimidine ribonucleotide salvage
What is pyrimidine ribonucleotide salvage?
Pyrimidine ribonucleotide salvage (GO:0010138) is the biological process that converts pyrimidine bases or pyrimidine ribonucleosides from nucleotide breakdown back into pyrimidine ribonucleotides, and it is important where there is no de novo pyrimidine nucleotide biosynthesis.
What genes are involved in pyrimidine ribonucleotide salvage?
Key genes include UPP1, UPP2, UCK1, UCK2, CDA, UPRT, NUDT22 and NME6, which together recycle uracil, uridine and cytidine into pyrimidine ribonucleotides.
Why is pyrimidine ribonucleotide salvage important in cancer?
Cancer cells can use salvage to survive de novo synthesis inhibition, and combined blockade of both pathways is a validated vulnerability in retinoblastoma.
How does NUDT22 relate to pyrimidine salvage?
NUDT22 promotes cancer growth through pyrimidine salvage, making it a potential therapeutic target.
What is the role of NME6 in ribonucleotide salvage?
NME6-dependent ribonucleotide salvage sustains mitochondrial transcription, linking salvage to mitochondrial gene expression.
How can CRISPR be used to study pyrimidine ribonucleotide salvage?
CRISPR knockout, point-mutation, knock-in and overexpression models can test whether salvage genes are required for nucleotide recycling, cancer growth or mitochondrial function.
Which diseases are linked to pyrimidine ribonucleotide salvage?
Cancer, therapy resistance, immunotherapy resistance and mitochondrial dysfunction have been linked to pyrimidine salvage.
What is the difference between de novo synthesis and salvage of pyrimidine ribonucleotides?
De novo synthesis builds pyrimidine rings from simple precursors, while salvage recycles preformed bases and ribonucleosides from nucleotide breakdown.
What methods are used to measure pyrimidine ribonucleotide salvage?
Metabolic flux analysis, RNA sequencing, proteomics, enzyme activity assays and mitochondrial transcription assays are commonly used.
Why is pyrimidine ribonucleotide salvage important in mitochondria?
Mitochondria rely on salvage to supply nucleotides for transcription, and NME6-dependent salvage sustains mitochondrial transcription.
Conclusion
GO:0010138 pyrimidine ribonucleotide salvage is a fundamental recycling process that restores pyrimidine ribonucleotides from nucleotide breakdown products, supporting DNA replication, RNA synthesis and mitochondrial transcription. Its importance is highlighted by cancer dependencies, where salvage can compensate for de novo synthesis inhibition and drive therapy resistance. CRISPR-based knockout, point-mutation, knock-in and overexpression models are powerful tools for dissecting the causal roles of salvage genes in health and disease. Continued research into this pathway will likely reveal new therapeutic opportunities in oncology, mitochondrial medicine and microbial physiology.
References
- 1. Gill R et al.. 2022. Control of a pyrimidine ribonucleotide salvage pathway in Pseudomonas oleovorans.. Arch Microbiol 204(7):383 PMID: 35689128
- 2. Smits MAJ et al.. 2023. Human ovarian aging is characterized by oxidative damage and mitochondrial dysfunction.. Hum Reprod 38(11):2208-2220 PMID: 37671592
- 3. Mollick T et al.. 2024. Retinoblastoma vulnerability to combined de novo and salvage pyrimidine ribonucleotide synthesis pharmacologic blockage.. Heliyon 10(1):e23831 PMID: 38332874
- 4. Scolaro T et al.. 2024. Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance.. Nat Cancer 5(8):1206-1226 PMID: 38844817
- 5. Wanrooij PH et al.. 2023. NME6: ribonucleotide salvage sustains mitochondrial transcription.. EMBO J 42(18):e114990 PMID: 37548337
- 6. Zhou W et al.. 2020. Purine metabolism regulates DNA repair and therapy resistance in glioblastoma.. Nat Commun 11(1):3811 PMID: 32732914
- 7. Walter M et al.. 2023. NUDT22 promotes cancer growth through pyrimidine salvage.. Oncogene 42(16):1282-1293 PMID: 36871087
- 8. Warner DF et al.. 2014. Nucleotide Metabolism and DNA Replication.. Microbiol Spectr 2(5) PMID: 26104350
